第二酪氨酸激酶结构域,FLT3 gene mutation
1)FLT3 gene mutation第二酪氨酸激酶结构域
2)tyramine kinase domain酪氨酸激酶结构域
1.Genistein is a high specific and noncompetitive inhibitor of epidermal growth factor receptortyramine kinase domain(EGFR-TK).染料木素是表皮生长因子受体酪氨酸激酶结构域(EGFR-TK)高度特异的非竞争性抑制剂。
英文短句/例句
1.A Study on the Prokaryotic and Eukaryotic Expression of Human EGFR Intracellular Tyrosine Kinase Domain;表皮生长因子受体胞内酪氨酸激酶结构域的原核及真核表达研究
2.Cloning and Expression of the Catalytic Domain of Protein Tyrosine Phosphatase SHP-1 and Screening of Its Inhibitors;蛋白质酪氨酸磷酸酶SHP-1催化结构域的克隆表达及抑制剂筛选
3.Expression and Purification of C-SH2 Domain-Containing Tyrosine Phosphatase and NMR StudiesSHP-2酪氨酸磷酸酶C-SH2结构域的表达纯化和NMR研究
4.The Cloning and Expression of Human PTPMEG1 Catalytic Domain and the Preparation of Its Polyclonal Antibody;蛋白质酪氨酸磷酸酶MEG1催化结构域的克隆表达及其多克隆抗体的制备
5.Preliminary Research of RAI16 Protein Interacting with Tec Tyrosine Kinase;Tec酪氨酸激酶作用蛋白RAI16的初步研究
6.Expression of receptor tyrosine kinase EphA1 in gastric cancer and its clinicopathological significance受体酪氨酸激酶EphA1 mRNA在胃癌中的表达
7.The progress in tyrosine kinase inhibitor has been reviewed, including the chemical structures and the pharmacophore models.本文综述了近年来酪氨酸激酶抑制剂的研究进展，包括抑制剂的结构和与激酶作用的药效团模型。
8.Casein Kinase 2 Interacts with and Phosphorylates Ataxin-3酪蛋白激酶2结合并磷酸化ataxin-3
9.The name is soluble f-m-s-like tyrosine kinase one?这种蛋白质叫做可溶解fms样酪氨酸激酶一，
10.The Research of Antibody Against Muscle-specific Tyrosine Kinase in Myasthenia Gravis among Chinese;重症肌无力患者酪氨酸激酶抗体的相关研究
11.Tec Tyrosine Protein Kinase Involved in Multidrug Resistance of Hepatocelluar Carcinoma;Tec酪氨酸蛋白激酶参与肝癌多药耐药的研究
12.c-Abl Stabilizes Estrogen Receptor by Phosphorylation and Regulates Its Transcription Activity;c-Abl非受体酪氨酸激酶调节ERα转录活性的研究
13.Study on the Prevalence of Protein Tyrosine Kinase JAK2V617F Mutation in the Western Population;西方人群中蛋白质酪氨酸激酶JAK2~（V617F）突变率研究
14.Expression and Clinical Significance of Receptor Tyrosine Kinase RON in Lung Carcinoma肺癌组织中酪氨酸激酶受体RON的表达及意义
15.Molecular targeted therapies:targeting receptor tyrosine kinases in the treatment of gastric cancer靶向于受体酪氨酸激酶的胃癌分子靶向治疗
16.Tyrosine Kinase Mutation and Acute Myeloid Leukemia with t(8;21)酪氨酸激酶突变与t(8;2急性髓系白血病
17.Advances in the inhibitors of FLT-3 receptor tyrosine kinaseFLT-3受体酪氨酸激酶抑制剂的研究进展
18.Multi-targeted protein tyrosine kinase inhibitor:research advances多靶点蛋白酪氨酸激酶抑制剂的研究进展
相关短句/例句
tyramine kinase domain酪氨酸激酶结构域
1.Genistein is a high specific and noncompetitive inhibitor of epidermal growth factor receptortyramine kinase domain(EGFR-TK).染料木素是表皮生长因子受体酪氨酸激酶结构域(EGFR-TK)高度特异的非竞争性抑制剂。
3)Discoidin domain receptor tyrosine kinases1a盘状结构域受体酪氨酸激酶1a
4)Tyrosine kinase酪氨酸激酶
1.Effect of PDT on the activity of protein tyrosine kinase and phosphatase in H22 cells;光动力疗法对H22细胞蛋白酪氨酸激酶及磷酸酶活性的影响
2.Effects and mechanisms of epidermal growth factor receptor of tyrosine kinase on cancer;表皮生长因子受体酪氨酸激酶抑制剂BPI-的抗肿瘤作用及其机制的研究
3.Expression, purification and bioactivity determination of epidermal growth factor receptor protein tyrosine kinase;表皮生长因子受体蛋白酪氨酸激酶的表达、纯化及活性测定
5)protein tyrosine kinase酪氨酸激酶
1.This paper reviewed recent progresses in the pharmacotherapeu- ties and clinical studies of the molecular-targeted anti-tumor drugs,including topoisomerase inhibitor,protein tyrosine kinase inhibitor,tumor angiogenesis inhibitor,PI3K-AKT-mTOR inhibitor and cyclin-de- pendent kinase inhib.笔者综述了近年来DNA拓扑异构酶抑制剂、蛋白酪氨酸激酶抑制剂、肿瘤新生血管生成抑制剂、磷脂酰肌醇-3激酶/蛋白激酶B/哺乳动物雷帕霉素靶体(PI3K-AKT-mTOR)信号通路抑制剂、细胞周期依赖性蛋白激酶抑制剂的临床应用和临床研究进展。
6)Tyrosine kinase A酪氨酸激酶A
1.Objective To observe the changes of tyrosine kinase A(TrkA) in different cerebral regions of ovariectomized rats.目的观察卵巢切除大鼠脑内不同部位酪氨酸激酶A(TrkA)表达的变化。
延伸阅读
第二1.复姓。见《通志．氏族四》。
